MRI and 18FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial
暂无分享,去创建一个
M. Weller | A. Hottinger | G. Tabatabai | U. Roelcke | T. Hundsberger | P. Roth | L. Remonda | F. Caparrotti | H. Wirsching | A. Ochsenbein | K. Conen | J. Weller | R. von Moos | Hans-Georg Wirsching